Mission Statement
We strive to be the leading provider of biopreservation tools for regenerative medicine; to facilitate basic and applied research and commercialization of new therapies by maintaining the health and function of biologic source material and finished products during manufacturing, distribution, and clinical administration. More about BioLife →
Investor & Company Information
NASDAQ: BLFS
NASDAQ: BLFS
$59.00 – $4,600.00
$35.00 – $1,010.00
$50.00 – $87.00